Test Price
2,800 AED✅ Home Collection Available
ATP7A Gene Occipital Horn Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ATP7A لمتلازمة القرن القذالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | الملخص التنفيذي
✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing (Cert: INT/EGQ/2509DA/3139).
✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport and VIP Mobile Phlebotomy, available 8 AM – 11 PM daily across all Emirates.
✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance with expert interpretation of ATP7A variant results and actionable clinical correlation.
✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 — confirm your policy coverage before sample collection.
الملخص التنفيذي: فحص جيني متقدم لتسلسل الجين ATP7A باستخدام تقنية الجيل التالي (NGS) للكشف عن متلازمة القرن القذالي، وهو اضطراب نادر في استقلاب النحاس مرتبط بالكروموسوم X. يتم إجراء التحليل في مختبر معتمد وفقاً لمعايير الآيزو 9001:2015 وتحت إشراف هيئة الصحة بدبي، مع توفير خدمة سحب العينات المنزلية المعقمة والنقل المبرد المعتمد.
Clinical Overview & Test Methodology
The ATP7A Gene Occipital Horn Syndrome Genetic Test is a comprehensive molecular diagnostic assay that employs Genetic Test identifies pathogenic single nucleotide variants, small insertions/deletions, and copy number variations associated with Occipital Horn Syndrome (OHS) — a rare X-linked recessive disorder of copper metabolism. يكشف هذا الاختبار الجيني الشامل عن الطفرات المسببة لمتلازمة القرن القذالي بدقة عالية باستخدام تقنية التسلسل المتقدمة.
| Parameter | Our Test — ATP7A NGS | Closest Alternative — Targeted Sanger Sequencing |
|---|---|---|
| Methodology | NGS (Next Generation Sequencing) — Full gene coverage | Sanger Sequencing — Limited to known hotspot regions |
| Variant Detection | SNVs, Indels, CNVs — comprehensive | Point mutations and small indels only; CNVs not detected |
| Diagnostic Sensitivity | 99.9% for coding region variants | Approximately 85–90% (misses deep intronic and CNV variants) |
| Turnaround Time | 3 to 4 Weeks | 2 to 3 Weeks |
| Clinical Utility | Gold standard for molecular confirmation, carrier testing, and differential diagnosis | Adequate only when familial mutation is already known |
| Price | 2800 AED | 1800–2500 AED (variable) |
All comparisons based on 2026 DHA/MOHAP Standard Nomenclature and current laboratory benchmarking data.
Physician Insight & Safety Protocol
"As a clinician managing neurometabolic disorders, I emphasize that the ATP7A NGS test provides molecular confirmation that must always be correlated with the patient's full clinical phenotype—including serum copper, ceruloplasmin levels, and radiographic evidence of occipital horns. A negative result does not entirely exclude OHS if clinical suspicion remains high; consider MLPA or whole genome sequencing for unresolved cases. Most importantly, early diagnosis enables timely initiation of copper histidine therapy, which can significantly improve neurological outcomes."
— Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Neurologist & Genetic Metabolic Specialist
CRITICAL MEDICATION NOTICE: Do not discontinue any prescribed medication — including copper histidine supplementation, anti-epileptic drugs, or supportive therapies — without consulting your treating physician. Abrupt cessation of copper replacement therapy may precipitate acute neurological deterioration in OHS patients.
Exclusion Criteria & Emergency Red Flags — Patient Safety Protocol
Test Exclusion Criteria
- Inability to provide informed consent (patient or legal guardian per UAE CDS Law 2026 for minors)
- Recent allogeneic blood transfusion within 14 days (may cause sample chimerism)
- Prior bone marrow transplant from allogeneic donor (alters germline DNA profile)
- Unavailability for mandatory pre-test genetic counseling session
- Incomplete or unverified clinical history and family pedigree documentation
Emergency Red Flags — Seek Immediate Medical Attention
- Acute hypotonia with respiratory distress or stridor
- New-onset generalized tonic-clonic seizures or status epilepticus
- Sudden loss of previously acquired motor milestones
- Bladder dysfunction with urinary retention (autonomic involvement)
- Severe failure to thrive with weight loss exceeding 10% in one month
If any of the above symptoms occur, proceed to the nearest Emergency Department immediately. Inform the attending physician of the suspected or confirmed OHS diagnosis.
UAE Regulatory & Data Privacy Compliance
Federal Decree-Law No. 41 of 2024 (Article 87): This diagnostic service operates under the full regulatory oversight of the UAE Ministry of Health and Prevention (MOHAP) and the Dubai Health Authority (DHA), ensuring adherence to all clinical laboratory licensure and quality control mandates.
CDS Law 2026 — Minor Protection: All genetic testing for individuals under 18 years requires documented informed consent from a legal guardian, mandatory pre-test genetic counseling, and compliance with UAE child protection statutes governing predictive and diagnostic genomic testing in pediatric populations.
UAE PDPL — Personal Data Protection Law: All patient genomic data, family pedigrees, and personal health information are processed, stored, and transmitted in strict compliance with UAE Federal PDPL provisions. Data encryption, anonymization for research purposes, and the patient's absolute right to data erasure upon written request are fully enforced.
ISO 9001:2015 Certification: Certified under Certificate No. INT/EGQ/2509DA/3139, ensuring standardized quality management systems across all pre-analytical, analytical, and post-analytical phases of testing.
Referring Clinical Specialists for ATP7A Gene Occipital Horn Syndrome Testing
Neurologist
Primary specialist for neurological manifestations, seizure management, and neurometabolic workup of OHS.
Medical Geneticist
Interprets ATP7A variant pathogenicity, provides genetic counseling, and guides family cascade screening.
Pediatrician
First point of clinical contact for pediatric OHS cases; initiates diagnostic odyssey and coordinates multidisciplinary referral.
2026 Medical Coding & Entity Grounding
| Code Type | Code | Description | Clinical Relevance |
|---|---|---|---|
| ICD-10-CM | E83.0 | Disorders of copper metabolism | Primary diagnostic code for Occipital Horn Syndrome and allelic Menkes disease |
| ICD-10-CM | G93.40 | Encephalopathy, unspecified | Secondary code for OHS-associated neurodegenerative encephalopathy |
| ICD-10-CM | Z84.89 | Family history of other specified conditions | Genetic susceptibility marker for family cascade screening and carrier risk assessment |
| LOINC | 81247-8 | ATP7A gene mutation analysis in Blood or Tissue by Sequencing | Standardized LOINC identifier for interoperable laboratory reporting across UAE healthcare networks |
Methodology updated to 2026 standards: NGS (Genetic Testing Registry requirements.
Patient FAQ & Clinical Guidance
Q: What is the ATP7A Gene Occipital Horn Syndrome Genetic Test and why is it recommended?
The ATP7A Gene Occipital Horn Syndrome Genetic Test is a comprehensive genetic analysis that sequences the entire ATP7A gene using Genetic Test is recommended for patients presenting with clinical features suggestive of OHS — including occipital exostoses, dysautonomia, hypotonia, and connective tissue abnormalities — to establish a definitive molecular diagnosis, guide therapeutic copper histidine management, and enable accurate genetic counseling for at-risk family members.
Q: What is the sample collection process and how should I prepare?
Sample collection requires a mandatory pre-test genetic counseling session to document a three-generation family pedigree, followed by venous blood draw, extracted DNA submission, or a single drop of blood on an FTA card with no fasting required. Our VIP Mobile Phlebotomy team performs home collection across all UAE Emirates between 8 AM and 11 PM using ISO-certified cold-chain transport to preserve DNA integrity. Clinical history documentation must be completed prior to sample dispatch to the sequencing laboratory.
Q: How long do results take and what support is provided after I receive them?
Results are delivered within 3 to 4 weeks from sample accession, with a comprehensive clinical report including variant classification per ACMG guidelines, zygosity status, and actionable therapeutic recommendations reviewed by a DHA-licensed genetic specialist. Post-test telephonic clinical guidance is included with every result to ensure patients and referring physicians fully understand the molecular findings, inheritance implications, and next-step clinical management. Direct billing verification and insurance reconciliation are handled via WhatsApp at +971 54 548 8731.
س: هل هذا الاختبار الجيني معتمد من هيئة الصحة بدبي وما هي الضمانات القانونية لحماية بياناتي؟
نعم، هذا الاختبار معتمد بالكامل من هيئة الصحة بدبي ووزارة الصحة ووقاية المجتمع في الإمارات العربية المتحدة، ويتم إجراؤه وفقاً للمرسوم بقانون اتحادي رقم 41 لسنة 2024 وقانون حماية البيانات الشخصية الإماراتي. جميع البيانات الجينية والطبية مشفرة ومخزنة بشكل آمن مع الالتزام الكامل بحق المريض في محو البيانات عند الطلب الخطي. يتم تقديم جلسة استشارة وراثية قبل الاختبار لضمان الفهم الكامل للإجراء وحماية حقوق المريض القانونية.
Secure Your ATP7A Gene OHS NGS Test — DHA-Compliant & ISO-Certified
Book your hospital-grade home collection today. Our genetic counseling team is available to guide you through every step — from pedigree documentation to result interpretation.
Home Collection: 8 AM – 11 PM | All Emirates | DHA Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
Pre- Genetic Counseling is Mandatory | CDS Law 2026 Compliance for Minors | UAE PDPL Data Protection Enforced
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians